Statement Of Cash Flows [Abstract]
| Concept |
2023-09-17 to 2024-09-14 |
2022-09-18 to 2023-09-16 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for finance income |
71,000,000
GBP
|
48,000,000
GBP
|
| Adjustments for decrease (increase) in trade and other receivables |
23,000,000
GBP
|
107,000,000
GBP
|
| Adjustments for increase (decrease) in trade and other payables |
113,000,000
GBP
|
15,000,000
GBP
|
| Adjustments for decrease (increase) in biological assets |
1,000,000
GBP
|
9,000,000
GBP
|
| Adjustments for amortisation expense |
100,000,000
GBP
|
82,000,000
GBP
|
| Adjustments for depreciation expense |
849,000,000
GBP
|
804,000,000
GBP
|
| Adjustments for undistributed profits of investments accounted for using equity method |
117,000,000
GBP
|
124,000,000
GBP
|
| Cash flows from (used in) investing activities [abstract] | ||
| Dividends received from investments accounted for using equity method, classified as investing activities |
105,000,000
GBP
|
107,000,000
GBP
|
| Cash flows from (used in) financing activities [abstract] | ||
| Dividends paid to equity holders of parent, classified as financing activities |
502,000,000
GBP
|
345,000,000
GBP
|
| Dividends paid to non-controlling interests, classified as financing activities |
13,000,000
GBP
|
7,000,000
GBP
|